Compare LAB & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAB | FDBC |
|---|---|---|
| Founded | 1999 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.2M | 313.1M |
| IPO Year | 2008 | 2000 |
| Metric | LAB | FDBC |
|---|---|---|
| Price | $0.71 | $55.74 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 13.1K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | ★ 61.54 | 35.00 |
| EPS | 0.26 | ★ 2.63 |
| Revenue | ★ $101,937,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | ★ $2.88 | $20.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.70 | $39.87 |
| 52 Week High | $1.72 | $56.00 |
| Indicator | LAB | FDBC |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 63.37 |
| Support Level | $0.70 | $41.48 |
| Resistance Level | $0.94 | N/A |
| Average True Range (ATR) | 0.05 | 1.46 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 0.25 | 79.89 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.